Baclofen induces catatonia in rats

Area of Science:

• Neuropharmacology
• Behavioral Neuroscience
• Drug Action Mechanisms

Background:

• Baclofen is a muscle relaxant known to interact with GABA receptors.
• Understanding the specific receptor subtypes involved in baclofen's effects is crucial for its therapeutic application and potential side effects.
• Catatonia is a complex neuropsychiatric condition characterized by motor immobility and other behavioral changes.

Purpose of the Study:

• To investigate the neurochemical mechanisms underlying baclofen-induced catatonia in a rat model.
• To determine the involvement of specific GABA receptor subtypes (GABAA vs. GABAB) in mediating baclofen's catatonic effects.
• To explore the roles of dopaminergic and cholinergic systems in baclofen-induced catatonia.

Main Methods:

• Administration of baclofen (10 and 20 mg/kg, i.p.) to rats to induce catatonia.
• Co-administration of GABAergic agents (muscimol, GABA) and receptor antagonists (bicuculline, homotaurine, delta-amino-n-valeric acid) to assess their modulatory effects.
• Inclusion of dopaminergic (bromocriptine) and cholinergic (scopolamine) agents to rule out their involvement.
• Observation and assessment of catatonic behaviors and their duration.

Main Results:

• Baclofen administration (10 and 20 mg/kg, i.p.) reliably induced catatonia in rats within 10 minutes, lasting for 3 hours.
• Muscimol and GABA potentiated baclofen-induced catatonia, while bicuculline, bromocriptine, and scopolamine did not alter it.
• GABAB receptor antagonists, homotaurine and delta-amino-n-valeric acid, effectively reversed baclofen-induced catatonia.

Conclusions:

• Baclofen-induced catatonia in rats is not mediated by GABAA receptors, dopaminergic, or cholinergic mechanisms.
• The findings strongly suggest that baclofen-induced catatonia is mediated through GABAB receptors.
• This study highlights the significant role of GABAB receptor activation in producing catatonic states.